ASTRO participates in FDA meeting on radiation safety
ASTRO continued to advance its Target Safely initiative by participating in the Food and Drug Administration's public meeting on Device Improvements to Reduce the Number of Under-Doses, Over-Doses, and Misaligned Exposures from Therapeutic Radiation on June 9 and 10, 2010. Read the press release.
Target Safely in Huffington Post
ASTRO President Tim R. Williams, M.D., wrote an article for the Huffington Post on our Target Safely initiative.
House Energy and Commerce subcommittee holds safety hearing
In response to the media articles, the House Energy and Commerce health subcommittee held a hearing Friday, February 26, 2010, at 10:00 a.m. in Washington, D.C., to learn more about quality and safety protocols in radiation oncology. A number of stakeholders testified, including ASTRO's Chairman Tim. R. Williams, M.D. Read the ASTROnews Web exclusive.
Self-assessment module on best practices
ASTRO has a new quality SAM titled “Defining Best Practices to Improve Clinical Care in Radiation Oncology.”
Questions patients may want to ask their doctors
ASTRO's Communications Committee has developed a list of questions patients may want to ask their doctors about radiation therapy, including questions about radiation safety. Jatinder Palta, Ph.D., also filmed a short video on radiation safety.
Red Journal supplement on protecting normal tissue
ASTRO has published a supplement to the Red Journal in March 2010 dedicated to the quantitative analysis of normal tissue effects in the clinic, edited by Lawrence Marks, M.D., Randall K. Ten Haken, Ph.D., and Mary K. Martel, Ph.D. This supplement was paid for by ASTRO. Read the ASTROnews Web exclusive.
ASTRO commits to six-point patient protection plan
ASTRO has committed to a six-point patient protection plan that will improve safety and quality and reduce the chances of medical errors.
Letter to the New York Times - January 25, 2010
ASTRO responds to a The New York Times article questioning the safety of radiation therapy treatments.